735 related articles for article (PubMed ID: 21929662)
21. Topiramate improves health-related quality of life when used to prevent migraine.
Diamond M; Dahlöf C; Papadopoulos G; Neto W; Wu SC
Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).
Kawata AK; Hareendran A; Shaffer S; Mannix S; Thach A; Desai P; Mikol DD; Ortmeier B; Bayliss M; Buse DC
Headache; 2019 Sep; 59(8):1253-1269. PubMed ID: 31168803
[TBL] [Abstract][Full Text] [Related]
23. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
24. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
Ford JH; Ye W; Ayer DW; Mi X; Bhandari S; Buse DC; Lipton RB
J Patient Rep Outcomes; 2023 Apr; 7(1):34. PubMed ID: 37016181
[TBL] [Abstract][Full Text] [Related]
25. Validity and reliability of the Migraine-Treatment Optimization Questionnaire.
Lipton RB; Kolodner K; Bigal ME; Valade D; Láinez MJ; Pascual J; Gendolla A; Bussone G; Islam N; Albert K; Parsons B
Cephalalgia; 2009 Jul; 29(7):751-9. PubMed ID: 19239676
[TBL] [Abstract][Full Text] [Related]
26. Chronic pain and depression in the quality of life of women with migraine--a controlled study.
Stuginski-Barbosa J; Dach F; Bigal M; Speciali JG
Headache; 2012 Mar; 52(3):400-8. PubMed ID: 22332812
[TBL] [Abstract][Full Text] [Related]
27. HIT-6 and MIDAS as measures of headache disability in a headache referral population.
Sauro KM; Rose MS; Becker WJ; Christie SN; Giammarco R; Mackie GF; Eloff AG; Gawel MJ
Headache; 2010 Mar; 50(3):383-95. PubMed ID: 19817883
[TBL] [Abstract][Full Text] [Related]
28. Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1).
Martin BC; Pathak DS; Sharfman MI; Adelman JU; Taylor F; Kwong WJ; Jhingran P
Headache; 2000 Mar; 40(3):204-15. PubMed ID: 10759923
[TBL] [Abstract][Full Text] [Related]
29. Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.
Raggi A; Giovannetti AM; Schiavolin S; Leonardi M; Bussone G; Grazzi L; Usai S; Curone M; Di Fiore P; D'Amico D
Qual Life Res; 2014 May; 23(4):1273-7. PubMed ID: 24129671
[TBL] [Abstract][Full Text] [Related]
30. Depression and anxiety: effect on the migraine-obesity relationship.
Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
[TBL] [Abstract][Full Text] [Related]
31. Disability and quality of life in different primary headaches: results from Italian studies.
Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
33. Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
Lipton RB; Tepper SJ; Reuter U; Silberstein S; Stewart WF; Nilsen J; Leonardi DK; Desai P; Cheng S; Mikol DD; Lenz R
Neurology; 2019 May; 92(19):e2250-e2260. PubMed ID: 30996060
[TBL] [Abstract][Full Text] [Related]
34. Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version.
Cole JC; Lin P; Rupnow MF
Cephalalgia; 2009 Nov; 29(11):1180-7. PubMed ID: 19830883
[TBL] [Abstract][Full Text] [Related]
35. Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine.
Gedikoglu U; Coskun O; Inan LE; Ucler S; Tunc T; Emre U
Cephalalgia; 2005 Jun; 25(6):452-6. PubMed ID: 15910570
[TBL] [Abstract][Full Text] [Related]
36. Validation of the revised Patient Perception of Migraine Questionnaire: measuring satisfaction with acute migraine treatment.
Revicki DA; Kimel M; Beusterien K; Kwong JW; Varner JA; Ames MH; Mahajan S; Cady RK
Headache; 2006 Feb; 46(2):240-52. PubMed ID: 16492233
[TBL] [Abstract][Full Text] [Related]
37. Reliability and convergent and discriminant validity of the Child Oral Health Impact Profile (COHIP Child's version).
Broder HL; Wilson-Genderson M
Community Dent Oral Epidemiol; 2007 Aug; 35 Suppl 1():20-31. PubMed ID: 17615047
[TBL] [Abstract][Full Text] [Related]
38. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
Kawata AK; Hsieh R; Bender R; Shaffer S; Revicki DA; Bayliss M; Buse DC; Desai P; Sapra S; Ortmeier B; Hareendran A
Headache; 2017 Oct; 57(9):1385-1398. PubMed ID: 28857154
[TBL] [Abstract][Full Text] [Related]
39. Post-traumatic stress disorder in episodic and chronic migraine.
Peterlin BL; Tietjen G; Meng S; Lidicker J; Bigal M
Headache; 2008 Apr; 48(4):517-22. PubMed ID: 18377377
[TBL] [Abstract][Full Text] [Related]
40. Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.
Ayer DW; Skljarevski V; Ford JH; Nyhuis AW; Lipton RB; Aurora SK
Headache; 2018 Sep; 58(8):1225-1235. PubMed ID: 30106172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
